反応 #159159
ord-a6e57e36acbf4e53ac58ba2a1589f9b6
反応方程式
反応物
試薬
反応条件
後処理
- 1温度the reaction mixture was cooled to 0° C.
- 2workup.WAITAfter 1.5 h
- 3温度the reaction mixture was warmed to RT
- 4洗浄washed with NaHCO3
- 5乾燥The organic phase was dried over MgSO4
- 6ろ過filtered
- 7濃縮concentrated
- 8その他The resulting residue was purified by HPLC
実験手順
2-Methoxycarbonylamino-3,3-dimethyl-butyric acid (37 mg, 0.227 mmol) EDC-HCl (44 mg, 0.227 mmol) and HOBt (32 mg, 0.237 mmol) were combined in DMF (2 mL) and stirred for 20 min at RT. (1-{6-[5-(4-{6-[2-(4-Cyano-pyrrolidin-2-yl)-3H-imidazol-4-yl]-naphthalen-2-yl}-phenyl)-1H-imidazol-2-yl]-5-aza-spiro[2.4]heptane-5-carbonyl}-2-methyl-propyl)-carbamic acid methyl ester-tris-hydrochloride (150 mg, 0.189 mg) was added, the reaction mixture was cooled to 0° C. and NMM (0.104 mL, 0.947 mmol) was added dropwise. After 1.5 h, the reaction mixture was warmed to RT. 30 min later, the mixture was diluted with EtOAc and washed with NaHCO3, then 1:1 brine/5M NaOH. The organic phase was dried over MgSO4, then filtered and concentrated. The resulting residue was purified by HPLC to afford the title compound (77 mg, 48%). MS (ESI) m/z 855 [M+H]+.